JB Chemicals rises on acquiring brand 'Azmarda' from Novartis
JB Chemicals is currently trading at Rs. 1610.35, up by 5.85 points or 0.36% from its previous closing of Rs. 1604.50 on the BSE.
The scrip opened at Rs. 1613.60 and has touched a high and low of Rs. 1615.25 and Rs. 1604.45 respectively. So far 403 shares were traded on the counter.
The BSE group 'A' stock of face value Rs. 2 has touched a 52 week high of Rs. 1984.75 on 28-Sep-2021 and a 52 week low of Rs. 1206.35 on 16-Apr-2021.
Last one week high and low of the scrip stood at Rs. 1690.00 and Rs. 1591.40 respectively. The current market cap of the company is Rs. 12418.07 crore.
The promoters holding in the company stood at 54.00%, while Institutions and Non-Institutions held 25.38% and 20.62% respectively.
JB Chemicals & Pharmaceuticals has successfully completed the acquisition of the brand 'Azmarda' from Novartis AG, Switzerland. Azmarda indicated for heart failure patients with reduced ejection fraction (HfrEF).
JB Chemicals & Pharmaceuticals is engaged in manufacturing of pharmaceutical specialties in various dosage forms, herbal remedies, diagnostics, generic drugs, active pharmaceutical ingredients (APIs).
